Showing results (1001-1010 of 6,317) with videos related to
Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|November 8, 2022
Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetesMei-Zhen Wu, Tiew-Hwa Katherine Teng, Wan-Ting Tay, et al.Diabetes, Obesity & Metabolism|February 17, 2023
Trajectory of glycated haemoglobin over time, using real-world data, in type 2 diabetes patients with obesity on a U-100 basal-bolus insulin regimenJieling Chen, Ludi Fan, Keisha Maughn, et al.Diabetes, Obesity & Metabolism|February 22, 2023
Trends and cyclic variation in the incidence of childhood type 1 diabetes in two Italian regions over 33 years and during the COVID-19 pandemicRosaria Gesuita, Ivana Rabbone, Vittorio Marconi, et al.Diabetes, Obesity & Metabolism|February 22, 2023
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world dataCristian Guja, János Tibor Kis, Martin Haluzík, et al.Diabetes, Obesity & Metabolism|February 22, 2023
Association between residual islet beta-cell function and achieving the target of time in range in inpatients with type 2 diabetes undergoing antidiabetic treatment: An observation studyZhang Xia, Wenjun You, Yuhao Li, et al.Diabetes, Obesity & Metabolism|February 22, 2023
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross-sectional dataChu Lin, Xingyun Zhu, Ruoyang Jiao, et al.Diabetes, Obesity & Metabolism|February 22, 2023
Use of the FreeStyle Libre system and diabetes treatment progression in T2DM: Results from a retrospective cohort study using a Canadian private payer claims databaseStewart B Harris, Fleur Levrat-GuillenDiabetes, Obesity & Metabolism|March 3, 2023
Effect of gastric distension with concurrent small intestinal saline or glucose infusion on incretin hormone secretion in healthy individuals: A randomized, controlled, crossover studyRyan J Jalleh, Laurence G Trahair, Tongzhi Wu, et al.Diabetes, Obesity & Metabolism|May 7, 2021
Do sodium-glucose co-transporter-2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?Rune E Kuhre, Carolyn F Deacon, Nicolai J Wewer Albrechtsen, et al.Diabetes, Obesity & Metabolism|May 5, 2021
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on AsiaQiuhe Ji, Linong Ji, Yiming Mu, et al.Pageof 632